Non-traumatic myelopathies represent a heterogeneous group of neurological conditions. Few studies report clinical and epidemiological profiles regarding the experience of referral services. Objective To describe clinical characteristics of a non-traumatic myelopathy cohort. Method Epidemiological, clinical, and radiological variables from 166 charts of patients assisted between 2001 and 2012 were compiled. Results The most prevalent diagnosis was subacute combined degeneration (11.4%), followed by cervical spondylotic myelopathy (9.6%), demyelinating disease (9%), tropical spastic paraparesis (8.4%) and hereditary spastic paraparesis (8.4%). Up to 20% of the patients presented non-traumatic myelopathy of undetermined etiology, despite the broad clinical, neuroimaging and laboratorial investigations. Conclusion Regardless an extensive evaluation, many patients with non-traumatic myelopathy of uncertain etiology. Compressive causes and nutritional deficiencies are important etiologies of non-traumatic myelopathies in our population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/0004-282X20160001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Quality of life and subjective well-being comparison between traumatic, nontraumatic chronic spinal cord injury, and healthy individuals in China.
PeerJ
December 2024
Department of Rehabilitation, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Background: Differentiating between traumatic and non-traumatic spinal cord injuries (NT-SCI) is critical, as these classifications may significantly impact patients' health outcomes and overall well-being, potentially resulting in differences in treatment protocols and therapeutic efficacy.
Objective: This study aims to compare the quality of life (QoL) and satisfaction with life (SWL) among individuals with traumatic spinal cord injuries (T-SCI), NT-SCI, and the healthy population in China.
Method: A quantitative, cross-sectional survey was conducted between July and December 2020 in the Rehabilitation and Physiotherapy Department of Tongji Hospital, Hubei University of Science and Technology.
Background: Degenerative Cervical Myelopathy (DCM) is the most common cause of non-traumatic, chronic spinal cord dysfunction worldwide, causing debilitating disability with a diminishing quality of life. The natural history of DCM is poorly understood. This is a preliminary report of the first 60 patients recruited to the MYelopathy NAtural History (MYNAH) Registry.
View Article and Find Full Text PDFClinical features and rehabilitation outcome after surgical treatment of spinal meningioma.
Spinal Cord Ser Cases
November 2024
Klinikgruppe Enzensberg, Department of Research, Development and Quality Assurance, Hopfen am See, Germany.
Study Design: Retrospective analysis of clinical routine data.
Objectives: Spinal meningioma is a common type of benign spinal tumor. Surgical removal is the standard therapeutic approach.
Canadian Association of Radiologists Spine Imaging Referral Guideline.
Can Assoc Radiol J
October 2024
North York General Hospital, Toronto, ON, Canada.
Article Synopsis
- The Canadian Association of Radiologists (CAR) Spine Expert Panel is composed of various medical professionals who collaborated to create diagnostic guidelines for specific spine-related clinical scenarios.
- A rapid scoping review identified 23 existing guidelines and applied the GRADE framework to develop 22 recommendation statements for 8 clinical situations relevant to spine health.
- These recommendations address conditions such as myelopathy, suspected spinal infection, and radicular pain, while linking certain scenarios to other established CAR referral guidelines for trauma and musculoskeletal issues.
New diagnosis of multiple sclerosis in the setting of recent Sinopharm COVID-19 vaccine (BBIBP-CorV) exposure: A series of clinical cases and updated review of the literature.
Curr J Neurol
January 2024
Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Multiple sclerosis (MS) is a leading cause of non-traumatic disability in young people, and there are few cases reported of demyelinating events after COVID-19 vaccination.
- In a study, 8 out of 338 newly diagnosed MS patients experienced their first symptoms within 6 weeks post-Sinopharm vaccine, with an average onset of 2 weeks.
- All patients were found to have demyelinating lesions on MRI and were treated with medications like intravenous steroids and Rituximab; however, more comprehensive studies are necessary to better understand the relationship between the vaccine and MS onset.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!